Filing Details
- Accession Number:
- 0001161697-22-000405
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-22 17:00:46
- Reporting Period:
- 2022-08-19
- Accepted Time:
- 2022-08-22 17:00:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1816477 | Jeffrey Carmen Del | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-08-19 | 14,140 | $14.05 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold in various lots from $14.00 to $14.23 per share. The listed sales price represents a weighted average price for the shares sold.
- Shares were sold for personal reasons, and does not relate to any disagreements with the Company. Mr. Del Carmen remains an officer of the Company.